This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Anand, S. S Search for Related Content PubMed PubMed Citation Articles by Anand, S. S Social Bookmarking                   What's this?

Vascular viewpoint

anands{at}mcmaster.ca

Question: To determine by how much statins reduce serum concentrations of low density lipo-protein (LDL) cholesterol according to drug, dose, and duration of treatment.

Population: Patients included in randomized, placebo-controlled trials of six statins (atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, rosuvastatin).

Design and methods: Meta analysis of 164 short-term, randomized trials including 24 000 drug-treated and 14000 placebo-treated patients. Studies were found by searching Medline, the Cochrane Collaboration, Web of Science databases, and BMJ.com. All double-blind, placebo-controlled trials were considered eligible. Excluded trials were those with no placebo group, any which lasted less than 2 weeks, those that used titrated doses, those that used combination drugs to lower cholesterol, crossover trials, or those with chronic renal failure patients. The efficacy of each statin was defined as the reduction of LDL for a given dose of a statin expressed as the change in the treated group minus that in the placebo group.

Results: The doses of atorvastatin, lovastatin, rosuvastatin and simvastatin used to lower LDL by an absolute amount of 1.8 mmol=l or 40% are shown in the table. Pravastatin and fluvastatin were a less effective treatment, with maximum doses (80 mg=day) lowering LDL by 1.58 mmol=l and 1.60 mmol=l, respectively. Statins increased high density lipoprotein cholesterol by 0.07 mmol=l on average with no dose effects observed. For safety outcomes, 1063=14 197 statin patients compared with 923=10 568 control patients reported one or more symptoms possibly associated with the drug. Rhabdomyolysis was observed in eight statin patients compared with five placebo patients.

StatinNumber of patients studiedDose (mg/day)LDL lowering(mmol/l)Atorvastatin4268101.80Fluvastatin^*4729801.58Lovastatin10648401.80Pravastatin^*9856801.60Rosuvastatin55551.80Simvastatin8839401.80

Conclusion: Statins can lower the LDL cholesterol concentration by an average of 1.8 mmol=l, and the LDL lowering effect varies across statin type and dose: simvastatin, lovastatin, atorvastatin and rosuvastatin appearing more effective, and fluvastatin and pravastatin appearing less effective.

Vascular Medicine, Vol. 8, No. 4, 289-290 (2003)
DOI: 10.1191/1358863x03vm518xx


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?